Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Captodiamine

Known as: 2-((p-(Butylthio)-alpha-phenylbenzyl)thio)-N,N-dimethylethylamine, 2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine, Captodiame 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BACKGROUND Prolonged treatment with benzodiazepines is common practice despite clinical recommendations of short-term use… Expand
Is this relevant?
2016
2016
Title Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor… Expand
Is this relevant?
2013
2013
The putative antidepressant captodiamine is a 5-HT2c receptor antagonist and agonist at sigma-1 and D3 dopamine receptors, exerts… Expand
Is this relevant?
2004
2004
SUMMARY Background and objectives: Discontinuation of benzodiazepines can be associated with the emergence of a withdrawal… Expand
Is this relevant?
1999
1999
AbstractObjective: To compare the effects of lorazepam, a benzodiazepine-type anxiolytic agent, with those of captodiamine, a non… Expand
Is this relevant?
1963
1963
 
Is this relevant?
1960
1960
1960
 
Is this relevant?
1960
1960
  • L. Abbott
  • Australian journal of dermatology
  • 1960
  • Corpus ID: 46499105
The drug chosen for trial was p-butylthiodiphenyl-methyl-2-dimethylaminoethyl sulphide hydrochloride, the approved name for which… Expand
Is this relevant?
1957
1957
 
Is this relevant?